Hoping to bag the boosted CSL dividend? Time is running out

Here's how you can secure the largest ever CSL dividend.

| More on:
A man points at a paper as he holds an alarm clock.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Last month, we covered the latest earnings from ASX 200 healthcare share CSL Limited (ASX: CSL). As we reported at the time, CSL's earnings report covering the 2023 financial year was well received by investors. And no doubt the latest CSL dividend was a factor there. 

Last month, CSL revealed that it had brought in a 13% increase in revenues for FY23 to US$13.31 billion. Net profit after tax before amortisation rose by 20% in constant currency to US$2.86 billion, while reported net profits were up 10% to US$2.61 billion.

This all enabled CSL to reveal a final dividend of US$1.29 per share, partially franked at 10%. That's the largest dividend (in US dollar terms) that CSL has ever paid out and a big rise over last year's corresponding payment of US$1.18 per share. It takes the company's full-year dividend payments to a total of US$2.36 per share. That's a 6% rise over FY22's levels.

We don't yet know exactly how much this division will be worth yet in Australian dollar terms. 13 September has been set aside for that determination. But at the current exchange rates, this would equate to a payment worth approximately $2.02 per share.

So this was clearly exciting news for investors. On the day the results were released, the CSL share price climbed a healthy 3.73%. Today, the company's shares remain more than 2% above where they were before the earnings came out, as you can see below:

However, while this new CSL dividend might be an exciting one for investors to contemplate, time is running out if they want to secure it. That's because the ex-dividend date for this payment is fast approaching.

How to bag the next CSL dividend

Whenever an ASX share announces a dividend payment, it also must pick a date preceding the payment day that determines the eligibility of shareholders to receive it. Put simply, if you own CSL shares before the ex-dividend date, you will get the dividend. But if you buy CSL shares on or after the ex-dividend date, you miss out.

As such, we tend to see a large share price drop whenever a share trades ex-dividend, reflecting this loss of value for new investors.

So for CSL's upcoming final dividend, the ex-dividend date has been set for 11 September. That's next Monday. This means that if you want to see the latest CSL dividend arrive in your bank account, you will need to be quick and own CSL shares as of close of trading tomorrow.

Payment day for this dividend will then come on 4 October next month.

Right now, CSL shares offer a dividend yield of 1.14%.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Female pharmacist smiles with a digital tablet.
Healthcare Shares

Sigma shares up 25% in 2 days as Chemist Warehouse merger looks set

The deal continues to create tailwinds for Sigma shares.

Read more »

A young woman holds her hand to her mouth in surprise as she reads something on her laptop.
Healthcare Shares

500 million reasons why ResMed shares are charging higher today

This growing company has big plans and is forecasting strong growth through to the end of the decade.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

'Exciting prospect': 2 ASX pharmaceutical shares to keep a close eye on

These companies have developed new drugs to treat vision loss and erectile dysfunction.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Guess which ASX 200 healthcare stock is up 12% on big Chemist Warehouse news

Investors appear to believe this news could be a sign that the deal will go ahead.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Healthcare Shares

Up 630% this year AND profitable! This small ASX healthcare share is glowing

Why has this stock delivered incredible returns this year? Let's find out.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

Can the CSL share price push back above $300?

The biotech last traded there on September 9.

Read more »

A man wearing a white coat holds his hands up and mouth open with joy.
Share Gainers

If you'd invested $6,000 in the ASX 300 stock in January, you'd have $22,551 today!

Shareholders in the ASX 300 stock have the FDA to thank for much of this year’s success.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Healthcare Shares

Guess which small cap ASX stock is rocketing 45% on benchmark agreement

What is getting investors excited on Friday? Let's find out.

Read more »